ATE384078T1 - Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten - Google Patents

Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten

Info

Publication number
ATE384078T1
ATE384078T1 AT03775022T AT03775022T ATE384078T1 AT E384078 T1 ATE384078 T1 AT E384078T1 AT 03775022 T AT03775022 T AT 03775022T AT 03775022 T AT03775022 T AT 03775022T AT E384078 T1 ATE384078 T1 AT E384078T1
Authority
AT
Austria
Prior art keywords
shrew
therapy
neuromuscular diseases
paralytic
peptides
Prior art date
Application number
AT03775022T
Other languages
English (en)
Inventor
John M Stewart
Bradley J Steeves
Karl Vernes
Original Assignee
Bioprospecting Nb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprospecting Nb Inc filed Critical Bioprospecting Nb Inc
Application granted granted Critical
Publication of ATE384078T1 publication Critical patent/ATE384078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03775022T 2002-11-18 2003-11-18 Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten ATE384078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42768202P 2002-11-18 2002-11-18

Publications (1)

Publication Number Publication Date
ATE384078T1 true ATE384078T1 (de) 2008-02-15

Family

ID=32326580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03775022T ATE384078T1 (de) 2002-11-18 2003-11-18 Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten

Country Status (8)

Country Link
US (1) US7485622B2 (de)
EP (1) EP1601691B1 (de)
AT (1) ATE384078T1 (de)
AU (1) AU2003283160A1 (de)
CA (1) CA2544467C (de)
DE (1) DE60318749T2 (de)
ES (1) ES2300625T3 (de)
WO (1) WO2004046178A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ES2185606T3 (es) 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
US7119168B2 (en) * 2002-11-18 2006-10-10 Bioprospecting Nb Inc. Paralytic peptide for use in neuromuscular therapy
US7427601B2 (en) * 2004-06-24 2008-09-23 Schwarz Pharma Ag Method for treating tremor
PL1781276T3 (pl) 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect
JP5749154B2 (ja) 2008-03-19 2015-07-15 ソリシメド・バイオファーマ・インコーポレーテッド Ｔｒｐｖ６カルシウムチャネル活性阻害による癌治療のためのペプチド組成物
EP2445932B1 (de) * 2009-06-26 2018-02-28 Soricimed Biopharma Inc. Soriciden-abgeleitete peptide und verfahren zum nachweisen von trpv-6-krebsarten und medikamentenverabreichung
EP2895504B1 (de) 2012-09-14 2019-05-08 John M. Stewart Trpv3-agonisten zur behandlung von hauterkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
JPH10236963A (ja) * 1997-02-26 1998-09-08 Sagami Chem Res Center カルシウムチャンネル拮抗剤
AU7389098A (en) * 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations

Also Published As

Publication number Publication date
ES2300625T3 (es) 2008-06-16
US7485622B2 (en) 2009-02-03
EP1601691B1 (de) 2008-01-16
DE60318749T2 (de) 2009-01-22
CA2544467C (en) 2014-02-18
AU2003283160A1 (en) 2004-06-15
WO2004046178A2 (en) 2004-06-03
US20060217302A1 (en) 2006-09-28
EP1601691A2 (de) 2005-12-07
WO2004046178A3 (en) 2004-07-22
AU2003283160A8 (en) 2004-06-15
CA2544467A1 (en) 2004-06-03
DE60318749D1 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
BG101841A (bg) Инхибитори на клетъчна адхезия
NO20030895D0 (no) Ny anvendelse av dipeptidyl peptidase IV inhibitorer
ATE549028T1 (de) Stabile analoga von glp-1
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
ATE271128T1 (de) Inhibitoren der il-6 aktivitaet
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
TR199802537T2 (xx) Peptit t�revleri.
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE384078T1 (de) Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten
AP1795A (en) Peptide deformylase inhibitors.
BR0312889A (pt) Polipeptìdeo t20 peguilado
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
ATE244712T1 (de) Piperazino-derivative als neurokininantagonisten
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
DE69535460D1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
NO991653D0 (no) Immunogenisk tumor frigjorte partikler (TLP)-blanding
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
GB0221169D0 (en) Crystal
DE69434151D1 (de) Therapeutische inhaltsstoffe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties